(NECN) - Millennium: The Takeda Oncology Company has a clear and bold vision: to cure cancer.

CEO Anna Protopapas shares some of the dramatic advances in cancer care.

Protopapas talks about what it’s like working with a Japanese based parent company and details what U.S. companies can learn from that culture.

Additionally, she weighs in on why Millennium is committed to staying in Cambridge, Mass.

See the attached video for the complete discussion.